In accordance, it has been previously determined that lncRNA SNHG12 serves as a negative predictor of clinicopathological characteristics and survival in renal cell, prostate, and nasopharyngeal carcinomas [43–45]. This evidence concerns the gene SNHG12 and nasopharyngeal carcinoma.